6 research outputs found

    I-PREGNO – prevention of unhealthy weight gain and psychosocial stress in families during pregnancy and postpartum using an mHealth enhanced intervention: a study protocol of two cluster randomized controlled trials

    Get PDF
    Background The transition to parenthood represents a critical life period with psychosocial, and behavioral changes and challenges for parents. This often increases stress and leads to unhealthy weight gain in families, especially in psychosocially burdened families. Although universal and selective prevention programs are offered to families, specific support often fails to reach psychosocially burdened families. Digital technologies are a chance to overcome this problem by enabling a low-threshold access for parents in need. However, there is currently a lack of smartphone-based interventions that are tailored to the needs of psychosocially burdened families. Aims The research project I-PREGNO aims to develop and evaluate a self-guided, smartphone-based intervention in combination with face-to-face counseling delivered by healthcare professionals for the prevention of unhealthy weight gain and psychosocial problems. The intervention is specifically tailored to the needs of psychosocially burdened families during the pregnancy and postpartum period. Methods In two cluster randomized controlled trials in Germany and Austria (N = 400) psychosocially burdened families will be recruited and randomized to i) treatment as usual (TAU), or ii) I-PREGNO intervention (self-guided I-PREGNO app with counseling sessions) and TAU. We expect higher acceptance and better outcomes on parental weight gain and psychosocial stress in the intervention group. Discussion The intervention offers a low cost and low-threshold intervention and considers the life situation of psychosocially burdened families who are a neglected group in traditional prevention programs. After positive evaluation, the intervention may easily be implemented in existing perinatal care structures in European countries such as Germany and Austria. Trial registration Both trials were registered prospectively at the German Clinical Trials Register (Germany: DRKS00029673; Austria: DRKS00029934) in July and August 2022

    The Photographic Now: David Claerbout’s Vietnam

    No full text
    L’installation vidéo Vietnam, 1967, near Duc Pho, reconstruction after Hiromichi Mine (2000) de David Claerbout pose la question du photographic now qui désigne aussi bien l’état présent de la photographie que l’état du présent photographique. L’oeuvre reproduit ou, plus précisément, recompose la photographie de presse d’un avion américain abattu par sa propre artillerie. L’artiste belge voyage sur les lieux de l’accident et prend une série de photos du paysage. Il en tire une vidéo à laquelle il superpose l’image de l’avion qui explose en plein ciel, obtenant ainsi une image temporellement hybride et médialement inclassable. Cette étude analyse le processus de reconstruction numérique et d’animation de l’image ; elle s’intéresse au « devenir signal » de l’image et s’interroge sur les possibilités de réactualiser le temps photographique.David Claerbout’s video installation, Vietnam, 1967, near Duc Pho, reconstruction after Hiromichi Mine (2000), questions the “photographic now,” the present state of photography and its new relation to the present. The piece reproduces, or more exactly recomposes, a press photograph of an American airplane shot down by friendly fire. The Belgian artist travelled to the site of the accident and took a series of photos of the landscape. He then assembled these stills into a video animation onto which he superimposed the still image of the exploding plane. The result is an image whose temporality is hybrid and whose mediality is unclassifiable. This study investigates the process of digital reconstruction and animation, and the “becoming signal” of the image, and questions the possibility of reactualizing the photographic past through digital screening

    I-PREGNO – prevention of unhealthy weight gain and psychosocial stress in families during pregnancy and postpartum using an mHealth enhanced intervention: a study protocol of two cluster randomized controlled trials

    No full text
    Background The transition to parenthood represents a critical life period with psychosocial, and behavioral changes and challenges for parents. This often increases stress and leads to unhealthy weight gain in families, especially in psychosocially burdened families. Although universal and selective prevention programs are offered to families, specific support often fails to reach psychosocially burdened families. Digital technologies are a chance to overcome this problem by enabling a low-threshold access for parents in need. However, there is currently a lack of smartphone-based interventions that are tailored to the needs of psychosocially burdened families. Aims The research project I-PREGNO aims to develop and evaluate a self-guided, smartphone-based intervention in combination with face-to-face counseling delivered by healthcare professionals for the prevention of unhealthy weight gain and psychosocial problems. The intervention is specifically tailored to the needs of psychosocially burdened families during the pregnancy and postpartum period. Methods In two cluster randomized controlled trials in Germany and Austria (N = 400) psychosocially burdened families will be recruited and randomized to i) treatment as usual (TAU), or ii) I-PREGNO intervention (self-guided I-PREGNO app with counseling sessions) and TAU. We expect higher acceptance and better outcomes on parental weight gain and psychosocial stress in the intervention group. Discussion The intervention offers a low cost and low-threshold intervention and considers the life situation of psychosocially burdened families who are a neglected group in traditional prevention programs. After positive evaluation, the intervention may easily be implemented in existing perinatal care structures in European countries such as Germany and Austria. Trial registration Both trials were registered prospectively at the German Clinical Trials Register (Germany: DRKS00029673; Austria: DRKS00029934) in July and August 2022
    corecore